Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
ciprofloxacin (som ciprofloxacinlaktat) 200 mg/100 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin (som adrenalinbitartrat) 1 mg/10 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
adrenalin (som adrenalinbitartrat) 1 mg/10 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
ciprofloxacin (som ciprofloxacinlaktat) 400 mg/200 ml, infusionsvätska, lösning, påse |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
ciprofloxacin (som ciprofloxacinlaktat) 400 mg/200 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
Pholcodine 400 microgram/mL oral solution |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
Product containing precisely carbocisteine 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
ciprofloxacin (som ciprofloxacinlaktat) 100 mg/50 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
ciprofloxacin (som ciprofloxacinlaktat) 100 mg/50 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 5 000 enheter/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 5 000 enheter/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 8 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
cisatrakurium (som cisatrakuriumbesylat) 5 mg/2,5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
cisatrakurium (som cisatrakuriumbesylat) 5 mg/2,5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dalteparinnatrium 10 000 enheter/4 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dalteparinnatrium 10 000 enheter/4 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
Clarithromycin 25 mg/mL oral suspension |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
cisatrakurium (som cisatrakuriumbesylat) 10 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
cisatrakurium (som cisatrakuriumbesylat) 10 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
sulfametoxazol 800 mg/10 ml + trimetoprim 160 mg/10 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
sulfametoxazol 800 mg/10 ml + trimetoprim 160 mg/10 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
sulfametoxazol 800 mg/10 ml + trimetoprim 160 mg/10 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
2 |
sulfametoxazol 800 mg/10 ml + trimetoprim 160 mg/10 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
2 |
Codeine phosphate 600 microgram/mL oral solution |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
kladribin 10 mg/10 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
kladribin 10 mg/10 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
abciximab 10 mg/5 ml injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
abciximab 10 mg/5 ml injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
Product containing precisely docusate sodium 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
fluorouracil (som fluorouracilnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
fluorouracil (som fluorouracilnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
klomipraminhydroklorid 25 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
klomipraminhydroklorid 25 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 3 000 enheter/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 3 000 enheter/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
paracetamol 500 mg/50 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
paracetamol 500 mg/50 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 4 000 enheter/0,4 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 4 000 enheter/0,4 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
acetylcystein 2 g/10 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
acetylcystein 2 g/10 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 50 milligram/1 milliliter and light kaolin 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
2 |
Product containing precisely calcium carbonate 50 milligram/1 milliliter and light kaolin 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
bemiparinnatrium 3 500 enheter/0,2 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
bemiparinnatrium 3 500 enheter/0,2 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 7 000 enheter/0,7 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 7 000 enheter/0,7 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
aciklovir (som aciklovirnatrium) 500 mg/20 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
aciklovir (som aciklovirnatrium) 500 mg/20 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
kodeinfosfat 60 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
kodeinfosfat 60 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 6 000 enheter/0,6 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 6 000 enheter/0,6 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
aciklovir (som aciklovirnatrium) 1 g/40 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
aciklovir (som aciklovirnatrium) 1 g/40 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
bemiparinnatrium 5 000 enheter/0,2 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
bemiparinnatrium 5 000 enheter/0,2 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cyclizinlaktat 50 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cyclizinlaktat 50 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
aciklovir (som aciklovirnatrium) 250 mg/10 ml infusionvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
aciklovir (som aciklovirnatrium) 250 mg/10 ml infusionvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cyklosporin 50 mg/ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
cyklosporin 50 mg/ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 8 000 enheter/0,8 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 8 000 enheter/0,8 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
adalimumab 40 mg/0,8 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
adalimumab 40 mg/0,8 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
cytarabin 1 g/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cytarabin 1 g/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 9 000 enheter/0,9 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 9 000 enheter/0,9 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
adenosin 30 mg/10 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
adenosin 30 mg/10 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
cytarabin 100 mg/ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
cytarabin 100 mg/ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 10 000 enheter/ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 10 000 enheter/ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
adenosin 6 mg/2 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
adenosin 6 mg/2 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cytarabin 2 g/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cytarabin 2 g/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 1 000 enheter/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 1 000 enheter/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 40 mg/mL and trimethoprim 8 mg/mL oral suspension |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
Sulfamethoxazole 40 mg/mL and trimethoprim 8 mg/mL oral suspension |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
2 |
alfakalcidol 1 mikrogram/0,5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
alfakalcidol 1 mikrogram/0,5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cytarabin 500 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cytarabin 500 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 40 000 enheter/ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 40 000 enheter/ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
bevacizumab 400 mg/16 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
bevacizumab 400 mg/16 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
cytarabin 500 mg/25 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
cytarabin 500 mg/25 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 2 000 enheter/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin alfa 2 000 enheter/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
alfentanil (som alfentanilhydroklorid) 5 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
alfentanil (som alfentanilhydroklorid) 5 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dalteparinnatrium 10 000 enheter/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
dalteparinnatrium 10 000 enheter/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |